Abstract
BackgroundOur recent study has revealed that many hospitalized patients with acquired long QT syndrome (ALQTS) are cancer patients. This study aims to determine the risk factors and outcomes of hospitalized cancer patients with ALQTS.MethodsWe performed a matched case-control study within a cohort of 10,180 cancer patients hospitalized between September 2013 and April 2016. Among them, 150 patients defined as having severe ALQTS with a markedly prolonged QT interval (QTc ≥ 500 ms) were compared with 293 age-, sex- and cancer-type-matched controls (non-ALQTS). Death as the endpoint was followed for up to 2 years. Cox regression and Kaplan-Meier survival analyses were performed to assess the effects of particular clinical variables on all-cause mortality. Multivariate logistic regression was performed to calculate odds ratios (OR) for various predictors of QT prolongation.ResultsThe mortality was significantly higher in ALQTS group (63.3% vs. 33.4%). Hypertension, hypokalemia, hypocalcemia, QT-prolonging drugs, infection, anemia, anti-microtubule agents were contributing factors to ALQTS. Renal insufficiency, male gender and hypokalemia were found to be independent risk factors for all-cause mortality in ALQTS group.ConclusionMarkedly prolonged QT interval was seen in 1.5% of hospitalized cancer patients. The all-cause mortality was high in cancer patients with severe ALQTS.
Highlights
With advances in early detection and therapeutics, the cancer survival rate continues to rise worldwide
The all-cause mortality was high in cancer patients with severe acquired long QT syndrome (ALQTS)
(2020) 6:3 factors associated with cancer therapeutics, termed Acquired Long QT Syndrome (ALQTS), is a key risk state that has been long overlooked in both cardiology and oncology
Summary
With advances in early detection and therapeutics, the cancer survival rate continues to rise worldwide. Cardiovascular disorder is a major cause of morbidity and mortality in cancer survivors [3]. These patients are prone to various types of arrhythmias, including tachycardias, bradycardias and conduction disorders [4, 5]. Sometimes cardiac arrhythmias can be life-threatening [6] In this regard, QT prolongation caused by acquired (2020) 6:3 factors associated with cancer therapeutics, termed Acquired Long QT Syndrome (ALQTS), is a key risk state that has been long overlooked in both cardiology and oncology. In 2017, our group reported cancer to be one of the major factors associated with all-cause mortality in ALQTS [7]. This study aims to determine the risk factors and outcomes of hospitalized cancer patients with ALQTS
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
